{"id":15521,"date":"2023-07-20T17:25:18","date_gmt":"2023-07-20T15:25:18","guid":{"rendered":"https:\/\/www.future-live.com\/vaginal-candidiasis-the-problem-of-recurrences\/"},"modified":"2026-03-24T10:09:38","modified_gmt":"2026-03-24T09:09:38","slug":"vaginal-candidiasis-the-problem-of-recurrences","status":"publish","type":"post","link":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/","title":{"rendered":"Vaginal candidiasis: the problem of recurrences"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column][vc_column_text]<span style=\"color: #333333;\"><strong>Candida vaginitis or vaginal candidiasis<\/strong> are very common disorders and constitute about 50% of all <span style=\"color: #005595;\"><strong><a style=\"color: #005595;\" href=\"https:\/\/www.future-live.com\/vaginite-che-cosa-e\/\">infectious vaginitis<\/a><\/strong><\/span>. They manifest with abundant, odorless, curd-like white discharge, accompanied by intense itching and significant inflammation of the external genitalia.<br \/> <\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column][tm_spacer size=&#8221;xs:10;sm:20;md:20;lg:60&#8243;][vc_column_text]<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 ez-toc-wrap-center counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Indice<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#Vaginal_candidiasis_the_problem_of_recurrences\" title=\"Vaginal candidiasis: the problem of recurrences\">Vaginal candidiasis: the problem of recurrences<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#Causes_of_recurrent_vaginal_candidiasis_the_role_of_the_intestine\" title=\"Causes of recurrent vaginal candidiasis: the role of the intestine\">Causes of recurrent vaginal candidiasis: the role of the intestine<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#The_importance_of_probiotics_in_preventing_recurrences\" title=\"The importance of probiotics in preventing recurrences\">The importance of probiotics in preventing recurrences<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#Decand_capsules\" title=\"Decand capsules\">Decand capsules<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#The_efficacy_of_Saccharomyces_cerevisiae_CNCM_I-3856_clinical_study_results\" title=\"The efficacy of Saccharomyces cerevisiae CNCM I-3856: clinical study results \">The efficacy of Saccharomyces cerevisiae CNCM I-3856: clinical study results <\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#The_dual_action_of_Saccharomyces_cerevisiae_CNCM_I-3856\" title=\"The dual action of Saccharomyces cerevisiae CNCM I-3856\">The dual action of Saccharomyces cerevisiae CNCM I-3856<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#Saccharomyces_cerevisiae_CNCM_I-3856_how_to_take_it\" title=\"Saccharomyces cerevisiae CNCM I-3856: how to take it \">Saccharomyces cerevisiae CNCM I-3856: how to take it <\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Vaginal_candidiasis_the_problem_of_recurrences\"><\/span><span style=\"color: #005599;\">Vaginal candidiasis: the problem of recurrences<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>[\/vc_column_text][tm_spacer size=&#8221;xs:5;sm:10;md:10;lg:32&#8243;][vc_column_text]<span style=\"color: #333333;\">Their prevalence among the female population is very wide: approximately 75% of women suffer from it at least once in their lifetime, and <strong>recurrences after the first episode are very common<\/strong>.<\/span><\/p>\n<p><span style=\"color: #333333;\">In particular, <strong>4% to 8% of women suffer from recurrent infections<\/strong> with at least four episodes per year, despite therapy with local antifungals (suppositories or cream) or oral medication.<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][vc_column_text]<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Causes_of_recurrent_vaginal_candidiasis_the_role_of_the_intestine\"><\/span><span style=\"color: #005599;\">Causes of recurrent vaginal candidiasis: the role of the intestine<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>[\/vc_column_text][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]<span style=\"color: #333333;\">The vaginal environment is subject to many factors that can cause an <strong>alteration of the physiological flora<\/strong>:<br \/><\/span><\/p>\n<ul>\n<li><span style=\"color: #333333;\">hormonal variations<br \/><\/span><\/li>\n<li><span style=\"color: #333333;\">contraception<br \/><\/span><\/li>\n<li><span style=\"color: #333333;\">pregnancy<\/span><\/li>\n<li><span style=\"color: #333333;\">use of antibiotics<br \/><\/span><\/li>\n<li><span style=\"color: #333333;\">habits and lifestyles<br \/><\/span><\/li>\n<\/ul>\n<p><span style=\"color: #333333;\">All these situations can create an environment favorable to the <strong>development of opportunistic pathogenic germs<\/strong> coming from:<br \/> <\/span><\/p>\n<ol>\n<li><span style=\"color: #333333;\">the external environment, through contact with surfaces that are not perfectly clean or sexual activity<br \/><\/span><\/li>\n<li><span style=\"color: #333333;\">the inside, specifically from the intestine<br \/><\/span><\/li>\n<\/ol>\n<p><span style=\"color: #333333;\"><strong>The intestine plays a role of particular importance in recurrences<\/strong> because it can often act as a true reservoir of opportunistic germs (bacteria and yeasts) capable of reaching the vagina due to the anatomical proximity between the anal and vaginal orifices.<br \/><\/span>[\/vc_column_text][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][vc_single_image image=&#8221;6826&#8243; img_size=&#8221;1295&#215;561&#8243; alignment=&#8221;center&#8221; css_animation=&#8221;zoomIn&#8221;][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]<span style=\"color: #333333;\">Specifically, <em><strong>Candida albicans<\/strong><\/em> is a saprophytic yeast, normally present in the intestine, capable of <strong>migrating to the vagina<\/strong>, adhering to the cells of the vaginal mucosa, and transforming from the non-pathogenic saprophytic form (round) to the pathogenic form (rod-shaped), triggering the production of substances responsible for the inflammatory process typical of Candida vaginitis.<br \/><\/span>[\/vc_column_text][tm_spacer size=&#8221;xs:60;sm:20;md:420;lg:60&#8243;][vc_column_text]<\/p>\n<h2 style=\"text-align: left;\"><span class=\"ez-toc-section\" id=\"The_importance_of_probiotics_in_preventing_recurrences\"><\/span><span style=\"color: #005595;\">The importance of probiotics in preventing recurrences<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>[\/vc_column_text][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]<span style=\"color: #333333;\">Based on these considerations,<strong> to prevent the recurrence of vaginal candidiasis<\/strong>, the importance of acting on two different fronts is clear:<br \/><\/span><\/p>\n<ul>\n<li><span style=\"color: #333333;\">At the intestinal level by intervening with a probiotic action: probiotics are able to counteract the proliferation of pathogenic germs and restore the intestinal flora to normal.<br \/><\/span><\/li>\n<li><span style=\"color: #333333;\">At the vaginal level with a specific action against Candida albicans aimed at limiting its adhesion and transformation into the pathogenic form.<br \/><\/span><\/li>\n<\/ul>\n<p>[\/vc_column_text][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][\/vc_column][\/vc_row][vc_row background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column][tm_spacer size=&#8221;xs:80;sm:60;md:60;lg:80&#8243;][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;rgba(0,0,0,0.5)&#8221;][\/vc_column][\/vc_row][vc_row effect=&#8221;firefly&#8221; firefly_color=&#8221;#ffffff&#8221; firefly_total=&#8221;30&#8243; firefly_min_size=&#8221;1&#8243; firefly_max_size=&#8221;3&#8243; background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column width=&#8221;1\/2&#8243;][tm_spacer size=&#8221;xs:10;sm:10;md:10;lg:10&#8243;][vc_single_image image=&#8221;11917&#8243; img_size=&#8221;medium&#8221; onclick=&#8221;custom_link&#8221; css_animation=&#8221;none&#8221; link=&#8221;https:\/\/www.future-live.com\/prodotto\/decand-20-capsule-gastroresistenti\/&#8221;][\/vc_column][vc_column width=&#8221;1\/2&#8243;][tm_spacer size=&#8221;xs:80;sm:10;md:10;lg:80&#8243;][vc_column_text]<\/p>\n<h2 style=\"text-align: center;\"><span class=\"ez-toc-section\" id=\"Decand_capsules\"><\/span><span style=\"color: #005595;\">Decand capsules<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\">Dietary supplement based on Saccharomyces cerevisiae CNCM I-3856, which helps restore the balance of vaginal flora and prevent the recurrence of candidiasis relapses.<\/p>\n<p>[\/vc_column_text][tm_spacer size=&#8221;xs:30;sm:30;md:30;lg:30&#8243;][vc_btn title=&#8221;Learn more&#8221; color=&#8221;primary&#8221; align=&#8221;center&#8221; css_animation=&#8221;none&#8221; link=&#8221;url:https%3A%2F%2Fwww.future-live.com%2Fprodotto%2Fdecand-20-capsule-gastroresistenti%2F|&#8221;][\/vc_column][vc_column][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;rgba(0,0,0,0.5)&#8221;][\/vc_column][\/vc_row][vc_row background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][vc_column_text]<\/p>\n<h2 style=\"text-align: left;\"><span class=\"ez-toc-section\" id=\"The_efficacy_of_Saccharomyces_cerevisiae_CNCM_I-3856_clinical_study_results\"><\/span><span style=\"color: #005595;\">The efficacy of Saccharomyces cerevisiae CNCM I-3856:<\/span> <span style=\"color: #005595;\">clinical study results <\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>[\/vc_column_text][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]<span style=\"color: #333333;\"><strong><em>\u00abRecovery of Saccharomyces cerevisiae CNCM I-3856 in vaginal samples of healty woman after oral administration\u00bb <\/em><\/strong><strong><em>Nutrients <\/em><\/strong><strong><em>24\/07\/2020<\/em><\/strong><\/span><\/p>\n<p><span style=\"color: #333333;\">This specific strain of <strong>Saccharomyces cerevisiae (CNCM I-3856)<\/strong>, a yeast specifically selected and studied for its ability to restore the balance of both intestinal and vaginal flora, was the subject of a clinical investigation. The goal was to evaluate its presence in the vagina of a group of healthy women who took a daily oral dose of 500mg for 4 weeks.<\/span><\/p>\n<p><span style=\"color: #333333;\"><strong>Results<\/strong>: After 4 weeks, <strong>Saccharomyces cerevisiae CNCM I-3856<\/strong> cells were found alive and viable in 80% of fecal samples and 21% of vaginal samples from the women who had taken it orally.<\/span><\/p>\n<p><span style=\"color: #333333;\">These data demonstrated the ability of live <strong>Saccharomyces cerevisiae CNCM I-3856<\/strong> cells to migrate from the intestine to the vagina and documented how the oral intake of this yeast allows for an early beneficial action starting at the intestinal level, which is a potential source of vaginal reinfection.<br \/><\/span>[\/vc_column_text][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][vc_single_image image=&#8221;6814&#8243; img_size=&#8221;1295&#215;890&#8243; alignment=&#8221;center&#8221; css_animation=&#8221;zoomIn&#8221; css=&#8221;.vc_custom_1638539485918{background-color: #ffffff !important;}&#8221;][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][vc_column_text]<\/p>\n<h2 style=\"text-align: left;\"><span class=\"ez-toc-section\" id=\"The_dual_action_of_Saccharomyces_cerevisiae_CNCM_I-3856\"><\/span><span style=\"color: #005595;\">The dual action of Saccharomyces cerevisiae CNCM I-3856<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>[\/vc_column_text][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]<span style=\"color: #333333;\"><strong>Saccharomyces cerevisiae CNCM I-3856<\/strong>, taken at a dose of <strong>500mg<\/strong> per day orally, acts on two levels:<br \/><\/span><\/p>\n<ol>\n<li><span style=\"color: #333333;\">As an <strong>INTESTINAL PROBIOTIC<\/strong> against enterotoxic yeasts and bacteria.<br \/><\/span><\/li>\n<li><span style=\"color: #333333;\">With a <strong>MORE SPECIFIC<\/strong> effect regarding vaginal Candida albicans infections, making pharmacological antifungal treatment more effective by:<br \/><\/span><\/li>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span style=\"color: #333333;\"><strong>Preventing the recurrence of relapses<br \/><\/strong><\/span><\/li>\n<li><span style=\"color: #333333;\"><strong>Reducing the inflammation that causes vaginal erythema<br \/><\/strong><\/span><\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<p>[\/vc_column_text][tm_spacer size=&#8221;xs:10;sm:20;md:420;lg:60&#8243;][vc_column_text]<\/p>\n<h2 style=\"text-align: left;\"><span class=\"ez-toc-section\" id=\"Saccharomyces_cerevisiae_CNCM_I-3856_how_to_take_it\"><\/span><span style=\"color: #005595;\">Saccharomyces cerevisiae CNCM I-3856<\/span>:<span style=\"color: #005595;\"> how to take it<\/span><br \/><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>[\/vc_column_text][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]<span style=\"color: #333333;\">In case of local antifungal therapy (suppositories\/cream): an intake of 500 mg (1 capsule) per day is recommended in association with the pharmacological treatment for at least 20\u201340 days.<\/span><\/p>\n<p><span style=\"color: #333333;\">In case of systemic antifungal therapy (tablets): an intake of 500 mg (1 capsule) per day is recommended starting from the discontinuation of the pharmacological treatment for at least 20\u201340 days.<\/span>[\/vc_column_text][tm_spacer size=&#8221;xs:60;sm:60;md:60;lg:60&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"[vc_row background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column][vc_column_text]Candida vaginitis or vaginal candidiasis are very common disorders and constitute about 50% of all infectious vaginitis. They manifest with abundant, odorless, curd-like white discharge, accompanied by intense itching and significant inflammation of the external genitalia. [\/vc_column_text][\/vc_column][\/vc_row][vc_row background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column][tm_spacer size=&#8221;xs:10;sm:20;md:20;lg:60&#8243;][vc_column_text] Vaginal candidiasis: the problem of recurrences [\/vc_column_text][tm_spacer size=&#8221;xs:5;sm:10;md:10;lg:32&#8243;][vc_column_text]Their prevalence among the female population is very wide: approximately 75% of women suffer from it at least once in their lifetime, and recurrences after the first episode are very common. In particular, 4% to 8% of women suffer from recurrent infections with at least four episodes per year, despite therapy with local antifungals (suppositories or cream) or oral medication.[\/vc_column_text][\/vc_column][\/vc_row][vc_row background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][vc_column_text] Causes of recurrent vaginal candidiasis: the role of the intestine [\/vc_column_text][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]The vaginal environment is subject to many factors that can cause an alteration of the physiological flora: hormonal variations contraception pregnancy use of antibiotics habits and lifestyles All these situations can create an environment favorable to the development of opportunistic pathogenic germs coming from: the external environment, through contact with surfaces that are not perfectly clean or sexual activity the inside, specifically from the intestine The intestine plays a role of particular importance in recurrences because it can often act as a true reservoir of opportunistic germs (bacteria and yeasts) capable of reaching the vagina due to the anatomical proximity between the anal and vaginal orifices.[\/vc_column_text][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][vc_single_image image=&#8221;6826&#8243; img_size=&#8221;1295&#215;561&#8243; alignment=&#8221;center&#8221; css_animation=&#8221;zoomIn&#8221;][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]Specifically, Candida albicans is a saprophytic yeast, normally present in the intestine, capable of migrating to the vagina, adhering to the cells of the vaginal mucosa, and transforming from the non-pathogenic saprophytic form (round) to the pathogenic form (rod-shaped), triggering the production of substances responsible for the inflammatory process typical of Candida vaginitis.[\/vc_column_text][tm_spacer size=&#8221;xs:60;sm:20;md:420;lg:60&#8243;][vc_column_text] The importance of probiotics in preventing recurrences [\/vc_column_text][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]Based on these considerations, to prevent the recurrence of vaginal candidiasis, the importance of acting on two different fronts is clear: At the intestinal level by intervening with a probiotic action: probiotics are able to counteract the proliferation of pathogenic germs and restore the intestinal flora to normal. At the vaginal level with a specific action against Candida albicans aimed at limiting its adhesion and transformation into the pathogenic form. [\/vc_column_text][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][\/vc_column][\/vc_row][vc_row background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column][tm_spacer size=&#8221;xs:80;sm:60;md:60;lg:80&#8243;][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;rgba(0,0,0,0.5)&#8221;][\/vc_column][\/vc_row][vc_row effect=&#8221;firefly&#8221; firefly_color=&#8221;#ffffff&#8221; firefly_total=&#8221;30&#8243; firefly_min_size=&#8221;1&#8243; firefly_max_size=&#8221;3&#8243; background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column width=&#8221;1\/2&#8243;][tm_spacer size=&#8221;xs:10;sm:10;md:10;lg:10&#8243;][vc_single_image image=&#8221;11917&#8243; img_size=&#8221;medium&#8221; onclick=&#8221;custom_link&#8221; css_animation=&#8221;none&#8221; link=&#8221;https:\/\/www.future-live.com\/prodotto\/decand-20-capsule-gastroresistenti\/&#8221;][\/vc_column][vc_column width=&#8221;1\/2&#8243;][tm_spacer size=&#8221;xs:80;sm:10;md:10;lg:80&#8243;][vc_column_text] Decand capsules &nbsp; Dietary supplement based on Saccharomyces cerevisiae CNCM I-3856, which helps restore the balance of vaginal flora and prevent the recurrence of candidiasis relapses. [\/vc_column_text][tm_spacer size=&#8221;xs:30;sm:30;md:30;lg:30&#8243;][vc_btn title=&#8221;Learn more&#8221; color=&#8221;primary&#8221; align=&#8221;center&#8221; css_animation=&#8221;none&#8221; link=&#8221;url:https%3A%2F%2Fwww.future-live.com%2Fprodotto%2Fdecand-20-capsule-gastroresistenti%2F|&#8221;][\/vc_column][vc_column][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;rgba(0,0,0,0.5)&#8221;][\/vc_column][\/vc_row][vc_row background_color=&#8221;custom&#8221; custom_background_color=&#8221;rgba(255,255,255,0.8)&#8221;][vc_column][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][vc_column_text] The efficacy of Saccharomyces cerevisiae CNCM I-3856: clinical study results [\/vc_column_text][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]\u00abRecovery of Saccharomyces cerevisiae CNCM I-3856 in vaginal samples of healty woman after oral administration\u00bb Nutrients 24\/07\/2020 This specific strain of Saccharomyces cerevisiae (CNCM I-3856), a yeast specifically selected and studied for its ability to restore the balance of both intestinal and vaginal flora, was the subject of a clinical investigation. The goal was to evaluate its presence in the vagina of a group of healthy women who took a daily oral dose of 500mg for 4 weeks. Results: After 4 weeks, Saccharomyces cerevisiae CNCM I-3856 cells were found alive and viable in 80% of fecal samples and 21% of vaginal samples from the women who had taken it orally. These data demonstrated the ability of live Saccharomyces cerevisiae CNCM I-3856 cells to migrate from the intestine to the vagina and documented how the oral intake of this yeast allows for an early beneficial action starting at the intestinal level, which is a potential source of vaginal reinfection.[\/vc_column_text][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][vc_single_image image=&#8221;6814&#8243; img_size=&#8221;1295&#215;890&#8243; alignment=&#8221;center&#8221; css_animation=&#8221;zoomIn&#8221; css=&#8221;.vc_custom_1638539485918{background-color: #ffffff !important;}&#8221;][tm_spacer size=&#8221;xs:60;sm:20;md:20;lg:60&#8243;][vc_column_text] The dual action of Saccharomyces cerevisiae CNCM I-3856 [\/vc_column_text][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]Saccharomyces cerevisiae CNCM I-3856, taken at a dose of 500mg per day orally, acts on two levels: As an INTESTINAL PROBIOTIC against enterotoxic yeasts and bacteria. With a MORE SPECIFIC effect regarding vaginal Candida albicans infections, making pharmacological antifungal treatment more effective by: Preventing the recurrence of relapses Reducing the inflammation that causes vaginal erythema [\/vc_column_text][tm_spacer size=&#8221;xs:10;sm:20;md:420;lg:60&#8243;][vc_column_text] Saccharomyces cerevisiae CNCM I-3856: how to take it [\/vc_column_text][tm_spacer size=&#8221;xs:32;sm:10;md:10;lg:32&#8243;][vc_column_text]In case of local antifungal therapy (suppositories\/cream): an intake of 500 mg (1 capsule) per day is recommended in association with the pharmacological treatment for at least 20\u201340 days. In case of systemic antifungal therapy (tablets): an intake of 500 mg (1 capsule) per day is recommended starting from the discontinuation of the pharmacological treatment for at least 20\u201340 days.[\/vc_column_text][tm_spacer size=&#8221;xs:60;sm:60;md:60;lg:60&#8243;][\/vc_column][\/vc_row]","protected":false},"author":2,"featured_media":12004,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[156],"tags":[32,175,176,178,177],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Vaginal candidiasis: the problem of recurrences - Future Live Srl<\/title>\n<meta name=\"description\" content=\"Recurrent vaginal candidiasis is very common and affects approximately 4-8% of women, with at least four episodes per year...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaginal candidiasis: the problem of recurrences - Future Live Srl\" \/>\n<meta property=\"og:description\" content=\"Recurrent vaginal candidiasis is very common and affects approximately 4-8% of women, with at least four episodes per year...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/\" \/>\n<meta property=\"og:site_name\" content=\"Future Live Srl\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FutureLivesrl\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-20T15:25:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-24T09:09:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.future-live.com\/wp-content\/uploads\/2023\/07\/donna-pensierosa-02.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"533\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sonia ferrari\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sonia ferrari\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/\"},\"author\":{\"name\":\"Sonia ferrari\",\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/person\/36e8a2b85e2477d93307768eaeea6841\"},\"headline\":\"Vaginal candidiasis: the problem of recurrences\",\"datePublished\":\"2023-07-20T15:25:18+00:00\",\"dateModified\":\"2026-03-24T09:09:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/\"},\"wordCount\":1104,\"publisher\":{\"@id\":\"https:\/\/www.future-live.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2023\/07\/donna-pensierosa-02.jpg\",\"keywords\":[\"#candida\",\"#candidosi\",\"#ginecologia\",\"#vaginiti\",\"recurrences\"],\"articleSection\":[\"Gynecology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/\",\"url\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/\",\"name\":\"Vaginal candidiasis: the problem of recurrences - Future Live Srl\",\"isPartOf\":{\"@id\":\"https:\/\/www.future-live.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2023\/07\/donna-pensierosa-02.jpg\",\"datePublished\":\"2023-07-20T15:25:18+00:00\",\"dateModified\":\"2026-03-24T09:09:38+00:00\",\"description\":\"Recurrent vaginal candidiasis is very common and affects approximately 4-8% of women, with at least four episodes per year...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#primaryimage\",\"url\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2023\/07\/donna-pensierosa-02.jpg\",\"contentUrl\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2023\/07\/donna-pensierosa-02.jpg\",\"width\":800,\"height\":533,\"caption\":\"donna candidosi vaginale recidiva\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.future-live.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaginal candidiasis: the problem of recurrences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.future-live.com\/#website\",\"url\":\"https:\/\/www.future-live.com\/\",\"name\":\"Future Live Srl\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.future-live.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.future-live.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.future-live.com\/#organization\",\"name\":\"Future Live\",\"url\":\"https:\/\/www.future-live.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png\",\"contentUrl\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png\",\"width\":1428,\"height\":1315,\"caption\":\"Future Live\"},\"image\":{\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/FutureLivesrl\/\",\"https:\/\/www.linkedin.com\/company\/future-live-srl\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/person\/36e8a2b85e2477d93307768eaeea6841\",\"name\":\"Sonia ferrari\",\"url\":\"https:\/\/www.future-live.com\/en\/author\/commercialefuture-live-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaginal candidiasis: the problem of recurrences - Future Live Srl","description":"Recurrent vaginal candidiasis is very common and affects approximately 4-8% of women, with at least four episodes per year...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/","og_locale":"en_US","og_type":"article","og_title":"Vaginal candidiasis: the problem of recurrences - Future Live Srl","og_description":"Recurrent vaginal candidiasis is very common and affects approximately 4-8% of women, with at least four episodes per year...","og_url":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/","og_site_name":"Future Live Srl","article_publisher":"https:\/\/www.facebook.com\/FutureLivesrl\/","article_published_time":"2023-07-20T15:25:18+00:00","article_modified_time":"2026-03-24T09:09:38+00:00","og_image":[{"width":800,"height":533,"url":"https:\/\/www.future-live.com\/wp-content\/uploads\/2023\/07\/donna-pensierosa-02.jpg","type":"image\/jpeg"}],"author":"Sonia ferrari","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sonia ferrari","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#article","isPartOf":{"@id":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/"},"author":{"name":"Sonia ferrari","@id":"https:\/\/www.future-live.com\/#\/schema\/person\/36e8a2b85e2477d93307768eaeea6841"},"headline":"Vaginal candidiasis: the problem of recurrences","datePublished":"2023-07-20T15:25:18+00:00","dateModified":"2026-03-24T09:09:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/"},"wordCount":1104,"publisher":{"@id":"https:\/\/www.future-live.com\/#organization"},"image":{"@id":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.future-live.com\/wp-content\/uploads\/2023\/07\/donna-pensierosa-02.jpg","keywords":["#candida","#candidosi","#ginecologia","#vaginiti","recurrences"],"articleSection":["Gynecology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/","url":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/","name":"Vaginal candidiasis: the problem of recurrences - Future Live Srl","isPartOf":{"@id":"https:\/\/www.future-live.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#primaryimage"},"image":{"@id":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.future-live.com\/wp-content\/uploads\/2023\/07\/donna-pensierosa-02.jpg","datePublished":"2023-07-20T15:25:18+00:00","dateModified":"2026-03-24T09:09:38+00:00","description":"Recurrent vaginal candidiasis is very common and affects approximately 4-8% of women, with at least four episodes per year...","breadcrumb":{"@id":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#primaryimage","url":"https:\/\/www.future-live.com\/wp-content\/uploads\/2023\/07\/donna-pensierosa-02.jpg","contentUrl":"https:\/\/www.future-live.com\/wp-content\/uploads\/2023\/07\/donna-pensierosa-02.jpg","width":800,"height":533,"caption":"donna candidosi vaginale recidiva"},{"@type":"BreadcrumbList","@id":"https:\/\/www.future-live.com\/en\/vaginal-candidiasis-the-problem-of-recurrences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.future-live.com\/en\/"},{"@type":"ListItem","position":2,"name":"Vaginal candidiasis: the problem of recurrences"}]},{"@type":"WebSite","@id":"https:\/\/www.future-live.com\/#website","url":"https:\/\/www.future-live.com\/","name":"Future Live Srl","description":"","publisher":{"@id":"https:\/\/www.future-live.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.future-live.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.future-live.com\/#organization","name":"Future Live","url":"https:\/\/www.future-live.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png","contentUrl":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png","width":1428,"height":1315,"caption":"Future Live"},"image":{"@id":"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/FutureLivesrl\/","https:\/\/www.linkedin.com\/company\/future-live-srl\/"]},{"@type":"Person","@id":"https:\/\/www.future-live.com\/#\/schema\/person\/36e8a2b85e2477d93307768eaeea6841","name":"Sonia ferrari","url":"https:\/\/www.future-live.com\/en\/author\/commercialefuture-live-com\/"}]}},"views":102,"_links":{"self":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/posts\/15521"}],"collection":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/comments?post=15521"}],"version-history":[{"count":6,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/posts\/15521\/revisions"}],"predecessor-version":[{"id":15527,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/posts\/15521\/revisions\/15527"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/media\/12004"}],"wp:attachment":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/media?parent=15521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/categories?post=15521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/tags?post=15521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}